VYNE Therapeutics Inc. reports

Company location: Bridgewater, NJ
Fiscal year end: 31 December

VYNE Therapeutics Inc. has filed 620 SEC EDGAR filings since 07 Jan 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 151-175 of 620 matching filings.

Per page

25

Current page

7

SC 13D File 005-90268

SC 13D

Filing date: 13 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38356

10-Q

Filing date: 13 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 13 Nov 2023
Reporting date: 13 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-90268

SCHEDULE 13G

Filing date: 02 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 30 Oct 2023
Reporting date: 27 Oct 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Oct 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Oct 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Oct 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Oct 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38356

10-Q

Filing date: 14 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

8-K

Filing date: 14 Aug 2023
Reporting date: 14 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38356

10-Q

Filing date: 11 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

8-K

Filing date: 11 May 2023
Reporting date: 11 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 01 May 2023
Reporting date: 28 Apr 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Apr 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Mar 2023
Reporting date: 20 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .